Volume 52, Issue 2 | Journal of Thrombosis and Thrombolysis

Journal of Thrombosis and Thrombolysis

A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science

Publishing model:: Hybrid

Submit your manuscript

Search all Journal of Thrombosis and Thrombolysis articles

Volume 52, Issue 2

August 2021

S.I. : Factor X: From Thrombokinase to Oral Anti-Coagulants and Beyond

Issue Editors:

Leonard M. Milstone,
Craig M. Jackson

46 articles in this issue

Guest editors’ introduction
Leonard M. Milstone
Craig M. Jackson
OriginalPaper 15 July 2021 Pages: 363 - 363
Factor Xa: Thrombokinase from Paul Morawitz to J Haskell Milstone
Leonard M. Milstone
ReviewPaper 23 January 2021 Pages: 364 - 370
Structure and function of factor X: properties, activation, and activity in prothrombinase. A retrospective in a historical context
Craig M. Jackson
ReviewPaper 16 March 2021 Pages: 371 - 378
Prothrombinase: the paradigm for membrane bound enzyme complexes; a memoir
Kenneth G. Mann
ReviewPaper 10 March 2021 Pages: 379 - 382
Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics
Rodney M. Camire
OriginalPaper 22 April 2021 Pages: 383 - 390
Roles of factor Xa beyond coagulation
Wolfram Ruf
OriginalPaper Open access 24 April 2021 Pages: 391 - 396
Factor Xa inhibitors: critical considerations for clinical development and testing
Richard C. Becker
ReviewPaper 15 May 2021 Pages: 397 - 402
From basic science to life-saving therapy: the rationale, and drug discovery efforts that led to the direct factor Xa inhibitor eliquis
Robert M. Knabb
Ruth R. Wexler
OriginalPaper 05 August 2021 Pages: 403 - 407
Discussion of talks from the symposium: Factor X: From thrombokinase to oral anti-coagulants and beyond
Leonard M. Milstone
Craig Jackson
Jeremy Wood
Letter 12 October 2021 Pages: 408 - 413
Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study
Nhu Lai
Aubrey E. Jones
Daniel M. Witt
OriginalPaper 23 January 2021 Pages: 414 - 418
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies
Toshiki Kuno
Bimmer Claessen
Roxana Mehran
OriginalPaper 11 March 2021 Pages: 419 - 428
MicroRNA-520d-3p alleviates hypoxia/reoxygenation-induced damage in human cardiomyocytes by targeting ATG-12
Kunpeng Wu
Ying Chen
Kui He
OriginalPaper 02 January 2021 Pages: 429 - 439
Downregulating LncRNA XIST attenuated contrast-induced nephropathy injury via regulating miR-133a-3p/NLRP3 axis
Xingli Liu
Wei Song
Liang Lv
OriginalPaper 02 January 2021 Pages: 440 - 453
The role of β-catenin in pulmonary artery endothelial-mesenchymal transformation in rats with chronic thromboembolic pulmonary hypertension
Meie Zeng
Shimou Chen
Chaosheng Deng
OriginalPaper 02 March 2021 Pages: 454 - 465
Awareness of thrombotic disease during lockdown: an unusual consequence of the COVID-19 pandemic
Matthaios Speletas
Letter to the Editor 02 January 2021 Pages: 466 - 467
A case of thrombotic thrombocytopenic purpura associated with COVID-19
Davide Nicolotti
Elena G. Bignami
Antonella Vezzani
Letter to the Editor 03 January 2021 Pages: 468 - 470
Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19
Mujan Varasteh Kia
Brandyn D. Lau
Elliott R. Haut
Report 28 January 2021 Pages: 471 - 475
Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients
Gwendolyn Ho
Jennifer R. Dusendang
Ashok Pai
BriefCommunication 01 February 2021 Pages: 476 - 481
Incidence of venous thromboembolism among patients with severe COVID-19 requiring mechanical ventilation compared to other causes of respiratory failure: a prospective cohort study
José Augusto Santos Pellegrini
Tatiana Helena Rech
Marina Verçoza Viana
OriginalPaper 18 February 2021 Pages: 482 - 492
Ovarian vein thrombosis after coronavirus disease (COVID-19) mimicking acute abdomen: two case reports
Merzouk Fatimazahra
Mahassine El Harras
Mohamed Sabry
Report 31 March 2021 Pages: 493 - 496
Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19
A Marco
P Marco
OriginalPaper 17 April 2021 Pages: 497 - 503
COVID 19 infection associated with thrombotic thrombocytopenic purpura
Gaurav Dhingra
Manideepa Maji
Uttam Kumar Nath
Report 27 April 2021 Pages: 504 - 507
The risk of venous thromboembolism and physical activity level, especially high level: a systematic review
H. Danin-Mankowitz
A. Ugarph-Morawski
P. Wändell
ReviewPaper Open access 02 January 2021 Pages: 508 - 516
Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus
Megan E. Bass
Tyree H. Kiser
Courtney Shakowski
OriginalPaper 09 January 2021 Pages: 517 - 522
Association between vitamin D deficiency and serum Homocysteine levels and its relationship with coronary artery disease
Monica Verdoia
Matteo Nardin
the Novara Atherosclerosis Study Group (NAS)
OriginalPaper 04 February 2021 Pages: 523 - 531
Management of isolated distal deep–vein thrombosis with direct oral anticoagulants in the RIETE registry
Jean-Philippe Galanaud
Javier Trujillo-Santos
the RIETE Investigators
OriginalPaper 28 November 2020 Pages: 532 - 541
Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?
Vittorio Pavoni
Lara Gianesello
Andrew Horton
ReviewPaper 10 May 2021 Pages: 542 - 552
Low molecular weight heparin and aspirin for prevention of deep vein thrombosisafter orthopaedic surgery: a systematic review and meta-analysis
Bo Chen
Nie Hu
OriginalPaper 02 January 2021 Pages: 553 - 559
Switching between direct oral anticoagulants: a systematic review and meta-analysis
Michele Romoli
Gabriello Marchetti
Stefano Urbinati
OriginalPaper 02 January 2021 Pages: 560 - 566
Safety and efficacy of direct oral anticoagulants across body mass index groups in patients with venous thromboembolism: a retrospective cohort design
Rachael M. Cardinal
Frank D’Amico
Gregory Castelli
OriginalPaper 02 January 2021 Pages: 567 - 576
Comparison of two escalated enoxaparin dosing regimens for venous thromboembolism prophylaxis in obese hospitalized patients
Caitlin M. Gibson
Courtney Hall
Jessica M. Schillig
OriginalPaper 05 January 2021 Pages: 577 - 583
Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?
Gianfranco Lapietra
Alessandra Serrao
Antonio Chistolini
ReviewPaper 08 January 2021 Pages: 584 - 589
Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy
Nir Livneh
Dionne Braeken
Avi Leader
BriefCommunication 01 February 2021 Pages: 590 - 596
Successful outcome with eculizumab treatment in a patient with antiphospholipid syndrome presenting with an unusual thrombotic storm
Jones T. Nauseef
Hana I. Lim
Maria T. DeSancho
BriefCommunication 22 November 2020 Pages: 597 - 600
Clinical validation of immunoassay HemosIL® AcuStar HIT-IgG (PF4-H) in the diagnosis of Heparin-induced thrombocytopenia
Zeina Marashi-Sabouni
Caroline Vayne
Laurence Camoin-Jau
OriginalPaper 01 January 2021 Pages: 601 - 609
Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system?
Hui Yin Lim
Brandon Lui
Prahlad Ho
OriginalPaper 24 February 2021 Pages: 610 - 619
Characteristics of carotid atherosclerosis in patients with plaque erosion
Ayami Kato
Yoshiyasu Minami
Junya Ako
OriginalPaper 10 March 2021 Pages: 620 - 627
Circle or semi‐circle hyper‐intensity on T1 high‐resolution isovolumetric examination (THRIVE) indicates the young age of experimentally induced caval thrombus
Wanyin Shi
Yadong Shi
Jianping Gu
OriginalPaper 09 April 2021 Pages: 628 - 634
Ecchymosis in critical coronavirus disease 2019 (COVID-19) patient in Tangerang, Indonesia: a case report
Allen Widysanto
T. D. Wahyuni
Angela
Report 17 November 2020 Pages: 635 - 639
Pulmonary manifestations of antiphospholipid syndrome: a retrospective analysis of 67 patients
Sevinc Sarinc Ulasli
Deniz Koksal
Sule Apras Bilgen
OriginalPaper 02 January 2021 Pages: 640 - 645
Prescribing trends of oral anticoagulants in England over the last decade: a focus on new and old drugs and adverse events reporting
Saima Afzal
Syed Tabish Razi Zaidi
Syed Shahzad Hasan
OriginalPaper Open access 05 March 2021 Pages: 646 - 653
Predicting mortality, thrombus recurrence and persistence in patients with post-acute myocardial infarction left ventricular thrombus
Wesley Yeung
Ching-Hui Sia
Joshua Ping-Yun Loh
OriginalPaper 02 January 2021 Pages: 654 - 661
Evaluation of direct thrombin inhibitors during a critical heparin shortage
Christine S. Ji
Russel J. Roberts
Rachel P. Rosovsky
OriginalPaper 05 January 2021 Pages: 662 - 673
The effect of hydroxychloroquine on platelet activation in model experiments
Karen Schreiber
Savino Sciascia
Ksenija Stach
OriginalPaper 02 January 2021 Pages: 674 - 679
Massive pulmonary embolism in a patient with nephrotic syndrome and single lung
Shi Hong Kai
Shaun Chook
Kang Giap Swee
Report 02 January 2021 Pages: 680 - 682
Coronary artery aneurysm presenting as acute coronary syndrome: two case reports and a review of the literature
Tuncay Taskesen
Kofi Osei
Magdi Ghali
ReviewPaper 20 March 2021 Pages: 683 - 688